CI Global Asset ManagementAnnounces Reinvested Distribution for CI First Asset Long Duration Fixed Income ETF

CI Global Asset ManagementAnnounces Reinvested Distribution for CI First Asset Long Duration Fixed Income ETF

NOT FOR DISSEMINATION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA

TORONTO–(BUSINESS WIRE)–
CI Global Asset Management (“CI GAM”) announces the following income distribution (the “Reinvested Distribution”) in respect of CI First Asset Long Duration Fixed Income ETF. In all cases, the Reinvested Distribution will be reinvested on or about January 18, 2021 to unitholders of record on January 15, 2021. The ex-dividend date for CI First Asset Long Duration Fixed Income ETF is January 14, 2021.

This confirmed amount is for the Reinvested Distribution. The Reinvested Distribution will not be paid in cash but will be reinvested and the resulting units immediately consolidated so that the number of units held by each investor will not change. As a result of this Reinvested Distribution, there will be no cash distribution for January 2021.

 

Trading Symbol

Reinvested

Distribution Amount

(to be reinvested and

consolidated)

CI First Asset Long Duration Fixed Income ETF

FLB

$0.024371

About CI Global Asset Management

CI Global Asset Management is one of Canada’s largest investment management companies. It offers a wide range of investment products and services and is on the web at www.ci.com. CI GAM is a subsidiary of CI Financial Corp. (TSX: CIX, NYSE: CIXX), an independent company offering global asset management and wealth management advisory services with $215.6 billion in total assets as of November 30, 2020.

This communication is intended for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to purchase exchange-traded funds (ETFs) managed by CI Global Asset Managementand is not, and should not be construed as, investment, tax, legal or accounting advice, and should not be relied upon in that regard. Individuals should seek the advice of professionals, as appropriate, regarding any particular investment. Investors should consult their professional advisors prior to implementing any changes to their investment strategies. These investments may not be suitable to the circumstances of an investor. Some conditions apply.

Commissions, management fees and expenses all may be associated with an investment in ETFs. You will usually pay brokerage fees to your dealer if you purchase or sell units of an ETF on recognized Canadian exchanges. If the units are purchased or sold on these Canadian exchanges, investors may pay more than the current net asset value when buying units of the ETF and may receive less than the current net asset value when selling them. Please read the prospectus before investing. Important information about an exchange-traded fund (ETF) is contained in its prospectus. ETFs are not guaranteed; their values change frequently and past performance may not be repeated.

CI Global Asset Management is a registered business name of CI Investments Inc.

©CI Investments Inc. 2021. All rights reserved.

CI Global Asset Management

416-642-1289

1-877-642-1289

www.firstasset.com

Murray Oxby

Vice-President, Corporate Communications

CI Global Asset Management

416-681-3254

[email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

Velodyne Lidar Powers Intelligent Traffic Management

Velodyne Lidar Powers Intelligent Traffic Management

New White Paper by Velodyne & University of Nevada, Reno’s Center for Applied Research Shows How Roadside Lidar is Key to Building Smart and Safe Transportation Infrastructure

SAN JOSE, Calif.–(BUSINESS WIRE)–Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) and University of Nevada, Reno’s Nevada Center for Applied Research today published a white paper that demonstrates lidar sensors’ ability to make transportation infrastructure more efficient, sustainable and safe. The white paper reports results of research using Velodyne’s lidar sensors to improve traffic analytics, increase pedestrian safety, reduce accidents and work toward facilitated use of autonomous vehicles.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210111005118/en/

The University of Nevada, Reno’s Nevada Center for Applied Research has placed Velodyne’s lidar sensors at crossing signs and intersections to help improve traffic analytics, congestion management and pedestrian safety. (Photo: Velodyne Lidar, Inc.)

The University of Nevada, Reno’s Nevada Center for Applied Research has placed Velodyne’s lidar sensors at crossing signs and intersections to help improve traffic analytics, congestion management and pedestrian safety. (Photo: Velodyne Lidar, Inc.)

“Velodyne is excited to provide lidar technology for systems that protect pedestrians at city intersections and reduce traffic accidents. We have a synergistic relationship with the University of Nevada, Reno, which is conducting cooperative research to further the development of safety solutions at the infrastructure level using smart technology. This white paper is important to describe our collaborative work for the safety and well-being of urban communities,” stated Marta Hall, Chief Marketing Officer at Velodyne.

The white paper, called “Roadside Lidar Helping to Build Smart and Safe Transportation Infrastructure,” can be downloaded here. Also available is a video called “Smart Cities: Improving Mobility, Access and Safety with Sensor Technology,” which can be viewed here. The video looks at how lidar can be a catalyst for smart city applications that improve public services and enhance safety and quality of life.

According to the research firm Markets and Markets, the Intelligent Transportation System (ITS) market for roadways is expected to grow from USD 17.9 billion in 2020 to USD 36.5 billion by 2025, at a CAGR of 15.3 percent. This growth can be attributed to increased pedestrian safety concerns, growing traffic congestion problems and smart city developments around the world.

The paper showcases research conducted by the University of Nevada, Reno’s Nevada Center for Applied Research, in conjunction with the Regional Transportation Commission of Washoe County, Regional Transportation Commission of Southern Nevada and the Nevada Department of Transportation. The project has deployed Velodyne’s Ultra Puck lidar sensors with traffic signals in real-world test environments, known as Living Laboratories, in Reno and Henderson, and sponsored by the Nevada Governor’s Office of Economic Development. It leveraged the data captured with Velodyne’s sensors to help improve traffic analytics, congestion management and pedestrian safety.

The project validated the feasibility of using roadside lidar sensors to provide high-accuracy, multimodal traffic trajectories by testing with different sensors, deployment methods and traffic scenarios. It demonstrated that roadside lidar data can support connected-and-autonomous vehicles (CAV), enhance traffic mobility and safety analysis and integrate with existing traffic infrastructure for automatic pedestrian/wildlife warning.

The project also achieved successful implementation of lidar-based automatic rectangular rapid flash beacons (RRFB), which unlike conventional RRFB, not only serve the crosswalk area but provide many additional functions. These include traffic performance data collection, jaywalk event recording and supporting infrastructure to serve CAVs and connected non-motorist roadway users.

Until recently, existing camera-based ITS traffic monitoring technologies have been widely used to study traffic flow rates, occupancy, average speed and spot speed. However, as alternative sensors come onto the market, the weaknesses of camera-based approaches become more apparent. For example, cameras have been shown to suffer in low-light conditions, are prone to optical illusions and do not allow for people’s privacy. It is anticipated that lidar will play a pivotal role in the growth of the ITS market because lidar sensors provide robust 3D data that allows for superior object detection and tracking in a wide variety of lighting and weather conditions while preserving anonymity and trust among the public.

“The white paper captures how lidar technology can be the catalyst for a revolutionary data change that will impact transportation planning and systems, and prepare our roadways for the future,” said Carlos Cardillo, Director, Nevada Center for Applied Research. “Velodyne sensors are powering ‘lidar-enhanced’ roads that address roadway congestion monitoring and near-crash analysis. They are also enabling data communications with connected vehicles to support eco-drive and collision avoidance applications.”

“The Nevada Center for Applied Research is conducting visionary smart cities research that can help significantly improve traffic safety and mitigate roadway dangers,” said Jon Barad, Vice President of Business Development, Velodyne Lidar. “Their work clearly demonstrates Velodyne’s lidar sensors are ready today to help build smarter, safer transportation infrastructure.”

About Velodyne Lidar

Velodyne Lidar (Nasdaq: VLDR, VLDRW) ushered in a new era of autonomous technology with the invention of real-time surround view lidar sensors. Velodyne is the first public pure-play lidar company and is known worldwide for its broad portfolio of breakthrough lidar technologies. Velodyne’s revolutionary sensor and software solutions provide flexibility, quality and performance to meet the needs of a wide range of industries, including autonomous vehicles, advanced driver assistance systems (ADAS), robotics, unmanned aerial vehicles (UAV), smart cities and security. Through continuous innovation, Velodyne strives to transform lives and communities by advancing safer mobility for all. For more information, visit www.velodynelidar.com.

Forward Looking Statements

This press release contains “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 including, without limitation, all statements other than historical fact and include, without limitation, statements regarding Velodyne’s target markets, new products, development efforts, competition. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “can,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Velodyne’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include Velodyne’s ability to manage growth; Velodyne’s ability to execute its business plan; uncertainties related to the ability of Velodyne’s customers to commercialize their products and the ultimate market acceptance of these products; the uncertain impact of the COVID-19 pandemic on Velodyne’s and its customers’ businesses; uncertainties related to Velodyne’s estimates of the size of the markets for its products; uncertainties regarding government regulation and adoption of lidar for pedestrian safety, traffic congestion and smart city applications; the rate and degree of market acceptance of Velodyne’s products; the success of other competing lidar and sensor-related products and services that exist or may become available; Velodyne’s ability to identify and integrate acquisitions; uncertainties related to Velodyne’s current litigation and potential litigation involving Velodyne or the validity or enforceability of Velodyne’s intellectual property; and general economic and market conditions impacting demand for Velodyne’s products and services. Velodyne undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Investor Relations

Andrew Hamer

Chief Financial Officer

[email protected]

Media

Landis Communications Inc.

Sean Dowdall

(415) 286-7121

[email protected]

KEYWORDS: United States North America California Nevada

INDUSTRY KEYWORDS: Hardware Construction & Property Data Management Technology University Audio/Video Education Performance & Special Interest General Automotive Transport Urban Planning Other Technology Automotive Software Public Transport

MEDIA:

Photo
Photo
The University of Nevada, Reno’s Nevada Center for Applied Research has placed Velodyne’s lidar sensors at crossing signs and intersections to help improve traffic analytics, congestion management and pedestrian safety. (Photo: Velodyne Lidar, Inc.)
Photo
Photo
A Reno, Nev. intersection as viewed by a camera (left) and lidar sensor (right). The lidar provides point cloud data to measure object size, distance and movement that cameras miss. (Photo: Velodyne Lidar, Inc.)
Photo
Photo
The University of Nevada, Reno’s Nevada Center for Applied Research has integrated Velodyne Ultra Puck lidar sensors (shown here) with traffic signals to detect, count and track pedestrians, cyclists and traffic. (Photo: Velodyne Lidar, Inc.)
Logo
Logo

VIA optronics to Virtually Present at the 23rd Annual Needham Growth Conference

VIA optronics to Virtually Present at the 23rd Annual Needham Growth Conference

NUREMBERG, Germany & NEW YORK–(BUSINESS WIRE)–VIA optronics AG (NYSE: VIAO) (“VIA”), a leading supplier of enhanced display solutions, today announced that Jürgen Eichner, Chief Executive Officer and Founder, and Daniel Jürgens, Chief Financial Officer, will present at the 23rd Annual Needham Growth Conference on Friday, January 15, 2021 at 5:30 p.m. Central European Time / 11:30 a.m. Eastern Time.

A live webcast, as well as a replay, of the presentation will be available on the company’s investor relations website at https://investors.via-optronics.com.

About VIA:

VIA is a leading provider of enhanced display solutions for multiple end-markets in which superior functionality or durability is a critical differentiating factor. Its customizable technology is well-suited for high-end markets with unique specifications as well as demanding environments that pose technical and optical challenges for displays, such as bright ambient light, vibration and shock, extreme temperatures and condensation. VIA’s interactive display systems combine system design, interactive displays, software functionality, cameras and other hardware components. VIA’s intellectual property portfolio, process know-how, and optical bonding and metal mesh touch sensor and camera module technologies provide enhanced display solutions that are built to meet the specific needs of its customers.

Investor Relations:

The Blueshirt Group

Monica Gould

[email protected]

212-871-3927

Lindsay Savarese

[email protected]

212-331-8417

KEYWORDS: Germany Europe United States North America New York

INDUSTRY KEYWORDS: Electronic Design Automation Engineering Technology Manufacturing Audio/Video Hardware

MEDIA:

Molson Coors Beverage Company to Webcast 2020 Fourth Quarter Earnings Conference Call

Molson Coors Beverage Company to Webcast 2020 Fourth Quarter Earnings Conference Call

GOLDEN, Colo. & MONTREAL–(BUSINESS WIRE)–
Molson Coors Beverage Company (NYSE: TAP, TAP.A; TSX: TPX.B, TPX.A) will host a webcast of the company’s 2020 Fourth Quarter Earnings Conference Call with investors and financial analysts at 11:00 a.m. Eastern Time (9:00 a.m. Mountain Time) on Thursday, February 11, 2021. The company will release earnings at approximately 7:00 a.m. Eastern Time on the same day.Company executives participating in the conference call will include Gavin Hattersley, President and Chief Executive Officer, and Tracey Joubert, Chief Financial Officer.

The webcast will be accessible via the Investor Relations page of the Molson Coors Beverage Company website, ir.molsoncoors.com. An online replay of the earnings call webcast will be posted within two hours following the live webcast and will be available until 11:59 p.m. Eastern Time on April 28, 2021.

Overview of Molson Coors Beverage Company

For over two centuries, Molson Coors has been brewing beverages that unite people for all of life’s moments. From Coors Light, Miller Lite, Molson Canadian, Carling, and Staropramen to Coors Banquet, Blue Moon Belgian White, Blue Moon LightSky, Vizzy, Coors Seltzer, Leinenkugel’s Summer Shandy, Creemore Springs, Hop Valley and more, Molson Coors produces some of the most beloved and iconic beer brands ever made. While the company’s history is rooted in beer, Molson Coors offers a modern portfolio that expands beyond the beer aisle as well.

Molson Coors Beverage Company is a publicly traded company that operates through Molson Coors North America and Molson Coors Europe, and is traded on the New York and Toronto Stock Exchanges. The company’s commitment to raising industry standards and leaving a positive imprint on our employees, consumers, communities and the environment is reflected in Our Imprint and our 2025 sustainability targets. To learn more about Molson Coors Beverage Company, visit www.molsoncoors.com, Molson Coors Our Imprint.com or on Twitter though @MolsonCoors.

About Molson Coors Canada Inc.

Molson Coors Canada Inc. (MCCI) is a subsidiary of Molson Coors Beverage Company. MCCI Class A and Class B exchangeable shares offer substantially the same economic and voting rights as the respective classes of common shares of MCBC, as described in MCBC’s annual proxy statement and Form 10-K filings with the U.S. Securities and Exchange Commission. The trustee holder of the special Class A voting stock and the special Class B voting stock has the right to cast a number of votes equal to the number of then outstanding Class A exchangeable shares and Class B exchangeable shares, respectively.

Media:

Marty Maloney

(773) 972-7780

Investor Relations:

Greg Tierney

(414) 931-3303

Traci Mangini

(415) 308-0151

KEYWORDS: Colorado United States North America Canada

INDUSTRY KEYWORDS: Food/Beverage Retail

MEDIA:

Logo
Logo

Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Corporate Milestones

Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Corporate Milestones

– Top-line Data for INTRIGUE Pivotal Phase 3 Study of QINLOCK® in Patients with Second-line GIST Expected in the Second Half of 2021 –

– Potential European Medicines Agency Approval of QINLOCK for Patients with Fourth-line GIST in the Second Half of 2021 –

– Company Planning to Finalize Pivotal Development Plans for Both Vimseltinib (DCC-3014) and Rebastinib in Second Half of 2021 –

WALTHAM, Mass.–(BUSINESS WIRE)–
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today provided a corporate update and highlighted key 2021 milestones in conjunction with its presentation at the 39th Annual J.P. Morgan Virtual Healthcare Conference. The Company will webcast its presentation today at 9:10 AM ET at https://investors.deciphera.com/news-events/events-presentations.

“Building on the successful U.S. launch of QINLOCK last year, we are focused in 2021 on expanding both the geographic reach for QINLOCK and the potential for this medicine to benefit patients with GIST even earlier in the course of their disease,” said Steve Hoerter, President and Chief Executive Officer of Deciphera. “We also look forward to sharing updated data from the vimseltinib (DCC-3014) and rebastinib programs, as well as finalizing our development plans to support potential registration for these two product candidates. With continued execution and investment in our pipeline, we believe we are well positioned to realize our 2021 goals and deliver important new medicines to patients.”

In 2021, the Company seeks to achieve the following milestones:

QINLOCK (ripretinib)

  • Report top-line data from the INTRIGUE Phase 3 clinical study of QINLOCK in patients with second-line gastrointestinal stromal tumor (GIST) in the second half of 2021.
  • Receive approval from the European Medicines Agency (EMA) for QINLOCK for the treatment of patients with fourth-line GIST in the second half of 2021.

Vimseltinib (DCC- 3014)

  • Present updated data from the Phase 1/2 study of vimseltinib (DCC-3014), an inhibitor of CSF1R, in patients with tenosynovial giant cell tumor (TGCT) in the second half of 2021.
  • Finalize the pivotal development plan for vimseltinib in TGCT in the second half of 2021.

Rebastinib

  • Present updated data from its Phase 1b/2 study of rebastinib, an inhibitor of TIE2, in combination with paclitaxel for patients with endometrial cancer in the second quarter of 2021.
  • Present updated data from its Phase 1b/2 study of rebastinib in combination with paclitaxel for patients with platinum-resistant ovarian cancer in the second half of 2021.
  • Finalize the pivotal development plan for the rebastinib/paclitaxel combination in the second half of 2021.

DCC-3116

  • Initiate the Phase 1 study of DCC-3116, an inhibitor of ULK kinase for the potential treatment of patients with cancers driven by mutations in RAS genes, in the second quarter of 2021, subject to FDA authorization to proceed under the investigational new drug (IND) application submitted in the fourth quarter of 2020.

Presentation at 39thAnnualJ.P. Morgan Healthcare Conference

Deciphera will webcast its corporate presentation from the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 9:10 AM ET. A live webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website at deciphera.com. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation. In conjunction with the conference, the Company has also updated its corporate presentation, which can be found here: https://investors.deciphera.com/news-events/events-presentations.

About Deciphera Pharmaceuticals

Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK is Deciphera’s FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Canada and Australia. For more information, visit www.deciphera.com and follow us on LinkedIn and Twitter (@Deciphera).

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, our expectations regarding 2021 corporate milestones and timing for these goals, including, without limitation, top-line data from our Phase 3 INTRIGUE study in second-line GIST, potential EMA approval of QINLOCK for the treatment of fourth-line GIST, finalizing pivotal study plans for vimseltinib (DCC-3014) in TGCT patients and for the rebastinib/paclitaxel combination, presenting updated data from the Phase 1/2 study of vimseltinib (DCC-3014) in TGCT patients, presenting updated data from the Phase 1b/2 study of rebastinib in combination with paclitaxel for patients with endometrial cancer and also from patients with platinum-resistant ovarian cancer, and initiating a phase 1 study of DCC-3116; expanding the geographic reach of QINLOCK; and the potential for QINLOCK to benefit patients with earlier-stage GIST. The words “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “seek,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, risks and uncertainties related to the severity and duration of the impact of COVID-19 on our business and operations, our ability to successfully demonstrate the efficacy and safety of our drug candidates and in additional indications for our existing drug, the preclinical or clinical results for our product candidates, which may not support further development of such product candidates, our ability to manage our reliance on sole-source third parties such as our third party drug substance and drug product contract manufacturers, comments, feedback and actions of regulatory agencies, our ability to commercialize QINLOCK and execute on our marketing plans for any drugs or indications that may be approved in the future, our ability to build and scale our operations to support growth in additional geographies, the inherent uncertainty in estimates of patient populations, competition from other products, our ability to obtain and maintain reimbursement for any approved product and the extent to which patient assistance programs are utilized, our ability to comply with healthcare regulations and laws, our ability to obtain, maintain and enforce our intellectual property rights, any or all of which may affect the initiation, timing and progress of clinical studies and the timing of and our ability to obtain additional regulatory approvals, and other risks identified in our Securities and Exchange Commission (SEC) filings, including our Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, and subsequent filings with the SEC. We caution you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. We disclaim any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. Any forward-looking statements contained in this press release represent our views only as of the date hereof and should not be relied upon as representing our views as of any subsequent date. We explicitly disclaim any obligation to update any forward-looking statements.

QINLOCK and the QINLOCK logo are registered trademarks, and Deciphera and the Deciphera logo are trademarks, of Deciphera Pharmaceuticals, LLC.

Investor Relations:

Jen Robinson

Deciphera Pharmaceuticals, Inc

[email protected]

781-906-1112

Media:

David Rosen

Argot Partners

[email protected]

212-600-1902

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Biotechnology Health Pharmaceutical Clinical Trials Oncology

MEDIA:

Logo
Logo

Quectel announces new 5G modules to drive 5G commercialization

PR Newswire

SHANGHAI, Jan. 11, 2021 /PRNewswire/ — Quectel Wireless Solutions (Stock Code: 603236.SS), the leading global supplier of IoT modules, announced that the company has launched three 5G New Radio (NR) Sub-6GHz modules during CES 2021, including the RM500Q-AE, the RM502Q-AE and the RM505Q-AE, to drive the mass deployment of 5G intelligent connections worldwide.

Leveraging the Qualcomm® Snapdragon™ X55 commercial 5G modem, the three modules feature super-fast speed, low latency, and enhanced carrier aggregation (CA) technology, and are now ready for sampling to support a wide range of enhanced Mobile Broadband (eMBB) and IoT applications such as fixed wireless access (FWA), 4K/8K live streaming, online meeting applications, telemedicine, smart transportation and industrial IoT (IIoT).

Capable of both standalone (SA) and non-standalone (NSA) modes, the three modules support worldwide coverage of 5G NR Sub-6GHz, LTE-A and WCDMA frequency bands and provide reliable 5G solutions to IoT customers globally. The other key features of the modules include:

  • Cover global 5G frequency bands
  • Multi-gigabit data rates, up to 5.0Gbps
  • DL 4 × 4 MIMO for 5G NR and LTE-A bands
  • Multi-constellation GNSS capabilities
  • Abundant interfaces: USB 3.0/3.1, PCIe 3.0 and eSIM
  • M.2 form factor, compatible with Quectel LTE-A Cat 6/Cat 12/Cat 16 modules

The three modules also integrate GNSS capabilities, with the RM505Q-AE supporting Active GPS L1/L5 signals for more accurate positioning services. This ensures industrial terminals like rugged tablet PCs and on-board computers can work in environments with weak signal such as valleys, forests and urban city canyons.

Currently, the RM502Q-AE has completed IC/FCC/ PTCRB/GCF/RED/RCM certifications, while the RM500Q-AE and the RM505Q-AE have completed CE/RCM certifications. These compulsory approvals with global launch firmware (FW) baseline help customers enter each local market quickly and reduce their cost of device development and certification.

Read the full text: https://www.quectel.com/infocenter/news/quectel-announces-new-5g-modules-to-drive-5gcommercialization.htm 

About Quectel

Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we create superior cellular and GNSS modules backed by outstanding support and services. Our growing global team of more than 2200 professionals, the largest in the IoT modules industry worldwide, ensures we are first to market and continue to set the pace of development. Listed on the Shanghai Stock Exchange (Stock Code: 603236.SS), our international leadership is devoted to advancing IoT across the globe.

For more information, visit Quectel’s websiteLinkedInFacebook and Twitter pages.

Ashley Liu

+86-551-6586 9386*8016
[email protected]

Cision View original content:http://www.prnewswire.com/news-releases/quectel-announces-new-5g-modules-to-drive-5g-commercialization-301205116.html

SOURCE Quectel

LasikPlus Sees Searches Soar with Yext Answers

Shortly after integrating Yext’s modern search to its website, LasikPlus answered more than 8,500 online questions and achieved a click-through rate greater than 25% for site search results.

PR Newswire

NEW YORK, Jan. 11, 2021 /PRNewswire/ — Yext, Inc. (NYSE: YEXT), the Search Experience Cloud company, today announced its success modernizing the website of LasikPlus, a leading provider of laser vision correction, with Yext Answers, the company’s revolutionary search product.

With Answers, which is powered by advanced natural language processing (NLP) and Bidirectional Encoder Representations from Transformers (BERT) technology, LasikPlus‘s website can now understand the more complex questions about the procedure posed by LASIK candidates on their website — and return official, direct answers. In addition, Yext Answers provides dynamic results, like videos and maps, as well as integrated calls-to-action.

Since launching with Yext Answers in the late summer, LasikPlus answered more than 8,500 questions on its website. The brand achieved a click-through rate greater than 25% for site search results.

“When you’re in consideration mode for LASIK eye surgery, you’re also in education mode, which means you have a lot of questions,” said LaGenia Watkins, Marketing Assistant at LasikPlus. “With Yext Answers, patients are able to get the answers they need right away. But the platform also gives us important insights into what people are searching for so we can make strategic communication updates to our site. And really listening to what our patients want is going to help us stay competitive.”

“For health decisions as important as vision correction, it’s critical for LASIK candidates to have access to all of the information they need to make the choice that’s right for them,” said Carrie Liken, Head of Industry for Healthcare at Yext. “LasikPlus has made this possible by incorporating a modern search experience to their website with Yext Answers. By providing up-to-date, accurate answers to their patients’ most critical questions, they are building even more trust and credibility — and that’s never been more important.”


Read more about Yext’s work equipping Lasik



Plus



 with state-of-the-art search technology here.

About Yext
The ultimate source for official answers about a business online should be the business itself. However, when consumers ask questions on company websites, too often they are left in the dark with wrong answers. Yext (NYSE: YEXT), the Search Experience Cloud, solves this problem by organizing a business’s facts so it can provide official answers to consumer questions — wherever people search. Starting with the company website, then extending across search engines and voice assistants, businesses around the world, like T-Mobile, Jaguar Land Rover, BBVA USA, and Kiehl’s — as well as organizations like the U.S. State Department and World Health Organization — trust Yext to radically improve the search experience on their websites and across the entire search ecosystem.

Yext’s mission is to help businesses and organizations around the world deliver official answers everywhere people search. Yext has been named a Best Place to Work by Fortune and Great Place to Work®, as well as a Best Workplace for Women. Yext is headquartered in New York City with offices in Amsterdam, Berlin, Chicago, Dallas, Geneva, London, Miami, Milan, Paris, San Francisco, Shanghai, Tokyo, and the Washington, D.C. area — and work-from-home offices all around the world.

CONTACT: Amanda Kontor, [email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/lasikplus-sees-searches-soar-with-yext-answers-301204925.html

SOURCE Yext, Inc.

Butterfly Network To Present At The 39th Annual J.P. Morgan Healthcare Conference

Butterfly Network aims to enable universal access to superior medical imaging, making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected

PR Newswire

GUILFORD, Conn., Jan. 11, 2021 /PRNewswire/ — Butterfly Network, Inc., an innovative digital health company that is working to enable universal access to superior medical imaging, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021, at 9:30 AM Eastern Time.

Butterfly Network announced in November that it will be listed on the New York Stock Exchange as BFLY in 2021 via a special purpose acquisition company merger (SPAC) with Longview Capital (NYSE: LGVW, expected to be NYSE: BFLY).

Butterfly’s Chief Executive Officer, Laurent Faracci, will be joined by Dr. John Martin, Chief Medical Officer; Gioel Molinari, President; and Stephanie Fielding, Chief Financial Officer, to discuss how Butterfly plans to fundamentally improve the access and portability of ultrasound technology.

The presentation by members of the leadership team may be accessed on Butterfly’s website at www.butterflynetwork.com/investors. An archived version of the webcast will be available for at least 30 days.

About Butterfly Network

Founded by Dr. Jonathan Rothberg in 2011 and led by CEO Laurent Faracci, Butterfly has created the world’s first handheld, single-probe whole-body ultrasound system, Butterfly iQ. Butterfly Network’s mission is to enable universal access to superior medical imaging, making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Through its proprietary Ultrasound-On-Chip™ technology, Butterfly Network is paving the way for earlier detection and remote management of health conditions around the world.  The Butterfly iQ can be purchased online today by healthcare practitioners in the United States, Australia, Belgium, Canada, Denmark, Finland, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.

Contact Information:

Investor Relations


[email protected]

Media Relations


[email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/butterfly-network-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301204881.html

SOURCE Butterfly Network

Lion Announces New Appointment to Board of Directors

PR Newswire

HONG KONG, Jan. 11, 2021 /PRNewswire/ — Lion Group Holding Ltd. (“Lion” or “the Company”) (NASDAQ: LGHL), operator of an all-in-one trading platform that offers a wide spectrum of products and services with a focus on Chinese investors, today announced Mr. Guandong (Gordon) Wang has been appointed as a director of the Board of Directors (the “Board”) on January 6, 2021.

Mr. Wang has approximately 14 years of financial industry background and approximately 10 years of quantitative trading and technology-related experience. Since 2016, Mr. Wang has been the chairman and general manager of Smart Alpha Asset Management Company and the general manager of Li Hai Hong King Co., Ltd. Prior to that, Mr. Wang has served in executive and senior leadership positions at a variety of companies, including Ping An Pioneer Capital Ltd., Ping An Securities Group (Holdings) Limited, AllstonTrading LLC., Transmarket Group, Citadel Investment Group, and Bank of America. Mr. Wang started his trading career from Citadel High Frequency Trading (HFT) group and gained his all-around skills in electronic market making and trading. He founded Ping An Pioneered Capital and managed over 10 Billion RMB quantitative funds. During the same time, he was also the head of Investment and Trading Division of Ping An Securities in charge of TRS and prop trading business. Mr. Wang received his bachelor’s degree in computer science from Peking University in China in 1998, his master of science’s degree in computer science and engineering from Nanyang Technological University in Singapore in 2001, and his master of science’s degree in computer science and engineering from Washington University in the USA in 2006, where he was also a PhD candidate and served as a research associate.

Mr. Chunning (Wilson) Wang, Chief Executive Officer at Lion, commented, “Mr. Wang’s diverse background and ample experience will be valuable as he plays a key role in Lion’s TRS trading business, which is expected to boost the Company’s revenue in the near future. His expertise will complement the Board’s existing skill set and provide valuable insight moving forward as we continue to deliver our services and develop innovative products to support the needs of our customers.”

About Lion

Lion Group Holding Ltd. (NASDAQ: LGHL) operates an all-in-one trading platform that offers a wide spectrum of products and services with a focus on Chinese investors. Through its state-of-the-art technology, Lion offers contract-for-difference (CFD) trading, insurance brokerage, futures brokerage, and securities brokerage on its platform, which can be accessed through applications available on the iOS, Android, Windows, and macOS systems. Lion’s customers are well-educated and affluent Chinese individual investors residing both inside and outside the PRC as well as institutional clients in Hong Kong. Additional information may be found at http://ir.liongrouphl.com.

Forward-Looking Statements

This press release contains, “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Lion’s actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “might” and “continues,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, Lion’s expectations with respect to future performance and anticipated financial impacts of the Business combination, the satisfaction of the closing conditions to the business combination and the timing of the completion of the business combination. These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from expected results. Most of these factors are outside the control of Lion and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the inability to maintain the listing of the post-acquisition company’s ADSs on NASDAQ following the business combination; (2) the risk that the business combination disrupts current plans and operations as a result of the announcement and consummation of the transactions described herein; (3) the inability to recognize the anticipated benefits of the business combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably and retain its key employees; (4) costs related to the business combination; (5) changes in applicable laws or regulations; (6) the possibility that Lion may be adversely affected by other economic, business, and/or competitive factors; and (7) other risks and uncertainties to be identified in the proxy statement/prospectus relating to the business combination, including those under “Risk Factors” therein, and in other filings with the Securities and Exchange Commission (“SEC”) made by Lion. Lion cautions that the foregoing list of factors is not exclusive. Lion cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Lion does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, subject to applicable law.

Contacts

Lion Group Holding

Tel: +852 2820 9011
Email: [email protected]

ICR, LLC

William Zima

Tel: +1 203 682 8233
Email: [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/lion-announces-new-appointment-to-board-of-directors-301204920.html

SOURCE Lion Group Holding Ltd.

Southern National Bancorp of Virginia, Inc. announces management changes

PR Newswire

MCLEAN, Va., Jan. 11, 2021 /PRNewswire/ — Southern National Bancorp of Virginia, Inc. (NASDAQ: SONA) (“Southern National” or the “Company”), and its wholly-owned subsidiary Sonabank (the “Bank”), today announced that Matthew A. Switzer has joined the Company as Executive Vice President and Chief Financial Officer.  Jeff Karafa has assumed the title of Chief Accounting Officer and will continue to be responsible for the accounting and financial reporting functions of the Company.

Mr. Switzer brings a wealth of financial services experience to Southern National.  He has spent the last fifteen years as an investment banker advising community banks on mergers and acquisitions, capital raising and strategy.  Mr. Switzer comes to the Company from Stephens Inc. where he was a managing director and prior to that was a managing director with Keefe, Bruyette & Woods, a Stifel Company.  A Richmond, Virginia native, Mr. Switzer has an MBA with a concentration in Finance from the University of North Carolina’s Kenan-Flagler Business School and a Bachelor of Science with High Distinction in Chemical Engineering from the University of Virginia.

“Our Company is very excited to have Matt join our team,” stated Dennis Zember, President and CEO of Southern National.  “I have worked with him in his previous roles for over ten years, and relied heavily on him for his advice and opinions on the ideas and strategies to build value and be distinct.  His experience in our industry, and his enthusiasm for our strategy will pay decades of dividends for our employees and our shareholders.”

About Southern National Bancorp of Virginia, Inc. 
As of September 30, 2020, Southern National had $3.15 billion in total assets, $2.52 billion in total loans and $2.22 billion in total deposits. Sonabank, the Company’s banking subsidiary provides a range of financial services to individuals and small and medium sized businesses through forty-two full-service branches in Virginia and Maryland and through certain internet and mobile applications.

Contact:
Dennis J. Zember, Jr., President and CEO 
Phone: 804-997-2406   
Southern National Bancorp of Virginia, Inc., NASDAQ Symbol SONA
Website: www.sonabank.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/southern-national-bancorp-of-virginia-inc-announces-management-changes-301204862.html

SOURCE Southern National Bancorp of Virginia, Inc.